- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Rheumatoid arthritis; Plaque psoriasis; Ankylosing spondylitis; Psoriatic arthritis; Juvenile idiopathic arthritis; Paediatric plaque psoriasis.
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 853KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 50KB)
Etanercept – November 2021
Etanercept: Injections 50 mg in 1 mL single use pre-filled syringes, 4; Rymti®
Last updated
4 March 2022